Lv1
40 积分 2026-04-12 加入
CDCP1: A promising diagnostic biomarker and therapeutic target for human cancer
19小时前
待确认
Biparatopic antibodies: therapeutic applications and prospects
13天前
已完结
A comparative study of the developability of full-length antibodies, fragments, and bispecific formats reveals higher stability risks for engineered constructs
22天前
已完结
The global patent landscape of bispecific antibodies: technological innovations and therapeutic applications
26天前
已完结
Multispecific T-cell engagers attract cancer drug developers
1个月前
已完结
皖公网安备34019202002308
